Catheter announces first procedures in France as LockeT expansion continues

Catheter Precision (VTAK) announces the first LockeT procedures in France. This milestone demonstrates significant progress in the adoption and commercialization of its technologies across the continent. Fatih Ayoglu, Sales Manager for EMEA & APAC at Catheter Precision, said, “This marks a pivotal moment in the clinical rollout of LockeT, which is designed to enhance procedural efficiency and patient outcomes after cardiac ablation procedures. Completing product evaluations so soon after the CE Mark was received is a testament to the need of a product like LockeT in the European Market. We look forward to expanding the commercial footprint and continuing our partnership with Professor Martins and the team at CHU Rennes.”